Page last updated: 2024-09-02

tanshinone and Kidney Diseases

tanshinone has been researched along with Kidney Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
He, Q; Jiang, X; Li, R; Long, F; Wang, L; Wang, T; Xu, M; Yang, Y; Zhang, X1
Huang, D; Wu, M; Yang, F; Ye, C1
Chen, Z; Feng, H; Gao, H; Peng, C; Tang, S; Xie, C; Yuan, Q; Zhang, Z1
Cheng, D; Jian, G; Liang, R; Wang, F; Wang, N; Zhang, G; Zhao, Q1
Feng, C; Gao, M; Li, C; Liu, M; Qi, X; Ren, J; Wu, M; Xie, X1
Li, J; Liao, J; Liu, L; Wan, J; Wu, X; Xie, H; Yu, K; Zhang, Y; Zhou, X1

Reviews

1 review(s) available for tanshinone and Kidney Diseases

ArticleYear
Renoprotective Effects of Tanshinone IIA: A Literature Review.
    Molecules (Basel, Switzerland), 2023, Feb-20, Volume: 28, Issue:4

    Topics: Abietanes; Animals; Fibrosis; Humans; Kidney; Kidney Diseases; Plant Extracts

2023

Other Studies

5 other study(ies) available for tanshinone and Kidney Diseases

ArticleYear
Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2/4 pathway in mice.
    Environmental toxicology, 2022, Volume: 37, Issue:7

    Topics: Abietanes; Acetaminophen; Animals; Kidney Diseases; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; RNA, Messenger; Signal Transduction

2022
Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A.
    BMC complementary medicine and therapies, 2022, Apr-19, Volume: 22, Issue:1

    Topics: Abietanes; Animals; Disease Models, Animal; Down-Regulation; Female; Fibrosis; Humans; Inhibins; Kidney; Kidney Diseases; Male; Mice; Rats; Ureteral Obstruction

2022
Tanshinone IIA Attenuates Contrast-Induced Nephropathy via Nrf2 Activation in Rats.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:6

    Topics: Abietanes; Animals; Antioxidants; Apoptosis; Cell Line; Contrast Media; Humans; Kidney Diseases; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza

2018
Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
    Environmental toxicology and pharmacology, 2013, Volume: 36, Issue:3

    Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Aristolochic Acids; Blood Chemical Analysis; Blotting, Western; Carcinogens; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Enzyme Induction; Kidney; Kidney Diseases; Liver; Luciferases; Male; Mice; Mice, Inbred C57BL; Plasmids; Real-Time Polymerase Chain Reaction; RNA; Spectrophotometry, Ultraviolet

2013
Tanshinone IIA prevents uric acid nephropathy in rats through NF-κB inhibition.
    Planta medica, 2012, Volume: 78, Issue:9

    Topics: Abietanes; Animals; Blood Urea Nitrogen; Chemokine CCL2; Creatinine; Drugs, Chinese Herbal; Interleukin-1beta; Kidney Diseases; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Uric Acid

2012